For risk managers, Covid-19 presents a stark reminder of the need to prepare for threats proactively.
Federal government stimulus measures could be on the way, as volatility in the stock markets continue and coronavirus spreads. We check in with dealmakers from Riverside, Merrill Corp. and Paul Hastings about the potential impact on mid-market M&A. In PE news, Blackstone backs healthcare technology company HealthEdge.
Thermo Fisher buys coronavirus test maker Qiagen in biggest healthcare of the deal of the year. Bregal Sagemount raises third fund. In more PE news, AEI, GTCR and FP make deals.
When a new coronavirus emerged out of China in January, Qiagen got to work on a test to detect the virus in bodily fluids. The test is now being evaluated at four hospitals in China and one in France. The diagnostic gives results in about one hour.
By supporting pain management solutions that don’t involve pills, experts say HR is in a position to help turn the tide on the crisis.